<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Introduced-in-House" dms-id="HD890BCB855B34D1D9208A3A49854D778" public-private="public" key="H" bill-type="olc"><metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>118 HR 5420 IH: WORK to Save Lives Act</dc:title>
<dc:publisher>U.S. House of Representatives</dc:publisher>
<dc:date>2023-09-12</dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
<distribution-code display="yes">I</distribution-code><congress display="yes">118th CONGRESS</congress><session display="yes">1st Session</session><legis-num display="yes">H. R. 5420</legis-num><current-chamber>IN THE HOUSE OF REPRESENTATIVES</current-chamber><action display="yes"><action-date date="20230912">September 12, 2023</action-date><action-desc><sponsor name-id="W000822">Mrs. Watson Coleman</sponsor> (for herself, <cosponsor name-id="R000609">Mr. Rutherford</cosponsor>, <cosponsor name-id="T000483">Mr. Trone</cosponsor>, <cosponsor name-id="M000194">Ms. Mace</cosponsor>, <cosponsor name-id="P000620">Ms. Pettersen</cosponsor>, <cosponsor name-id="T000469">Mr. Tonko</cosponsor>, <cosponsor name-id="N000147">Ms. Norton</cosponsor>, <cosponsor name-id="L000564">Mr. Lamborn</cosponsor>, <cosponsor name-id="C001097">Mr. Cárdenas</cosponsor>, <cosponsor name-id="C001117">Mr. Casten</cosponsor>, <cosponsor name-id="C001130">Ms. Crockett</cosponsor>, <cosponsor name-id="L000551">Ms. Lee of California</cosponsor>, <cosponsor name-id="S001226">Ms. Salinas</cosponsor>, <cosponsor name-id="G000551">Mr. Grijalva</cosponsor>, <cosponsor name-id="C001072">Mr. Carson</cosponsor>, <cosponsor name-id="C001125">Mr. Carter of Louisiana</cosponsor>, and <cosponsor name-id="J000032">Ms. Jackson Lee</cosponsor>) introduced the following bill; which was referred to the <committee-name committee-id="HED00">Committee on Education and the Workforce</committee-name></action-desc></action><legis-type>A BILL</legis-type><official-title display="yes">To require the Secretary of Labor to issue guidance and regulations regarding opioid overdose reversal medication and employee training.</official-title></form><legis-body id="HD7F9B2D5E7054A2EBFF69AD9E658F083" style="OLC"><section id="H370C77019D8F4500B90452FDF7780E67" section-type="section-one"><enum>1.</enum><header>Short title</header><text display-inline="no-display-inline">This Act may be cited as the <quote><short-title>Workplace Overdose Reversal Kits to Save Lives Act</short-title></quote> or the <quote>WORK to Save Lives Act</quote>.</text></section><section id="HB7BE563741F649C2BB8418BC50F05610"><enum>2.</enum><header>Non-mandatory guidance for employers concerning opioid overdose reversal medication</header><subsection id="HA816B744AEC74F038F58131BCC0FB94B"><enum>(a)</enum><header>In general</header><text display-inline="yes-display-inline">Not later than 270 days after the date of enactment of this Act, the Secretary of Labor, acting through the Occupational Safety and Health Administration, shall issue nonmandatory guidance to employers on—</text><paragraph id="H0406175824114FF4B0C6CF54500500B5"><enum>(1)</enum><text>acquiring and maintaining opioid overdose reversal medication; and</text></paragraph><paragraph id="HFAE2F1EA13C84CD49671CC31D4DE706F"><enum>(2)</enum><text>training employees on an annual basis on the usage of such medication.</text></paragraph></subsection><subsection id="H1D204F0F0E9D4860B846D3A8EB3484BB"><enum>(b)</enum><header>Employer defined</header><text display-inline="yes-display-inline">In this section, the term <term>employer</term> has the meaning given such term in section 3 of the Occupational Safety and Health Act of 1970 (<external-xref legal-doc="usc" parsable-cite="usc/29/652">29 U.S.C. 652</external-xref>), except that such term does not include the United States Postal Service.</text></subsection></section><section id="H26F3BD84AC174093AE3B0BAD34F233A6"><enum>3.</enum><header>Mandatory regulations for Federal agencies concerning opioid overdose reversal medication</header><subsection id="HFA081FC98B5F478F991056D567616C1F"><enum>(a)</enum><header>In general</header><text>Not later than 270 days after the date of enactment of this Act, the Secretary of Labor, acting through the Occupational Safety and Health Administration, shall issue regulations to require each Federal agency to—</text><paragraph id="H6CE862CC64B34DBAAE995437FE79B849"><enum>(1)</enum><text>acquire and maintain opioid overdose reversal medication; and</text></paragraph><paragraph id="H6FE997853CD345F8A0FD35D6D82C7C8C"><enum>(2)</enum><text>train employees on an annual basis on the usage of such medication.</text></paragraph></subsection><subsection id="HE40C77B2C1DA4B49819DC6AB3AE3464F"><enum>(b)</enum><header>Federal agency defined</header><text>In this section, the term <term>Federal agency</term> means any agency or instrumentality of the Federal Government, including the Veterans Health Administration, notwithstanding section 7425(b) of title 38, United States Code.</text></subsection></section></legis-body></bill> 

